Germany's Schott begins building plant in Russia
This article was originally published in Scrip
Executive Summary
Schott Pharmaceutical Packaging has signed an agreement with the administration of the Nizhny Novgorod region in Russia. Under the agreement, the division of Germany’s Schott will begin building a $94 million factory in the region to produce glass packaging materials for pharmaceuticals, with a capacity of approximately 300 million units in the mid-term. The factory will be located on a 30-hectare site in the Bor district that the company chose earlier (Scrip Online, November 30th, 2007). The project will be implemented in three phases, the first of which is scheduled to be completed next April. At this stage the plant will employ approximately 150 people to make primary pharmaceutical packaging. The company hopes to strengthen its position in Russia and other ex-Soviet republics where it has been supplying vials and ampoules from a plant in Hungary for several years.
You may also be interested in...
Poland's new law fixes prices and trade mark-ups of reimbursed drugs
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
Global pharma boosts business in Russia - Why Russia (introduction)
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Medvedev wants talks on trials mutual recognition with US and EU
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.